Publication Online – January 2016
This clinical practice statement used the RAND/University of
California, Los Angeles (UCLA) Appropriateness Method to look at clinical
scenarios for stage I to IVA endometrial cancer. It considers the impact of
risk group, histology, node dissection and node positivity on appropriate use
of adjuvant brachytherapy, external beam radiation therapy and chemoradiation,
as well as on sequencing of chemotherapy and radiation when both are given.
Read executive summaryRead full Analysis
Resources Recent Advances in Endometrial CancerRAND/UCLA Appropriate Method User’s Manual
Author SocietyAmerican Society for Radiation Oncology
ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.